Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Free Cash Flow (2016 - 2025)

Cumberland Pharmaceuticals' Free Cash Flow history spans 16 years, with the latest figure at $3025.0 for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 99.84% year-over-year to $3025.0; the TTM value through Dec 2025 reached $4.8 million, up 812.39%, while the annual FY2025 figure was $4.8 million, 812.39% up from the prior year.
  • Free Cash Flow for Q4 2025 was $3025.0 at Cumberland Pharmaceuticals, down from $163392.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $3.9 million in Q1 2025 and bottomed at -$2.2 million in Q1 2024.
  • The 5-year median for Free Cash Flow is $460124.0 (2024), against an average of $895667.1.
  • The largest annual shift saw Free Cash Flow skyrocketed 8778.52% in 2022 before it plummeted 759.5% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at -$43689.0 in 2021, then surged by 8778.52% to $3.8 million in 2022, then tumbled by 140.23% to -$1.5 million in 2023, then skyrocketed by 224.7% to $1.9 million in 2024, then tumbled by 99.84% to $3025.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Free Cash Flow are $3025.0 (Q4 2025), $163392.0 (Q3 2025), and $817315.0 (Q2 2025).